speb/financial-data huggingface dataset:
Financial ratios for VBIO — annual report dated 2022-12-31
Total revenue: 1840000
Gross profit: 299000
Operating income: -10098000
Net income: -10096000
Capital expenditures: 11000
Operating cash flow: -8919000
Depreciation & amortization: 174000
Net tangible assets: 3630000
Owner earnings: -9933000
Return on net tangible assets (%): -273.6363636363636
Buffett classification: The Gruesome
Stock price: 1088
Shares outstanding: 3200824
Book value: 3630000
P/B ratio: 959.3654303030303
Market cap (USD): 3482496512
Debt to equity: 0.14600550964187328
Current ratio: 2.825346112886049
Quick ratio: 2.365814696485623
COGS to revenue (%): 83.75
R&D to revenue (%): 94.02173913043478
SG&A to revenue (%): 471.03260869565213
Free cash flow (dilution-adjusted): -9328000
Buyback yield (%): 0
Retained earnings: -29642000
Inventory turnover: 1.7856315179606026
Receivables turnover: 17.19626168224299
Capitalized R&D asset: 1730000
ROCI (R&D-adjusted, %): -156.18415691752517
FCF margin (%): -506.9565217391304
Rule of 40 score: -506.9565217391304
Financial ratios for VBIO — annual report dated 2023-12-31
Total revenue: 1176000
Gross profit: 287000
Operating income: -8245000
Net income: -8244000
Capital expenditures: 118000
Operating cash flow: -8511000
Depreciation & amortization: 182000
Net tangible assets: 3580000
Owner earnings: -8180000
Return on net tangible assets (%): -228.49162011173183
Buffett classification: The Gruesome
Stock price: 30.6
Shares outstanding: 3200824
Book value: 3580000
P/B ratio: 27.35899843575419
Market cap (USD): 97945214.4
Debt to equity: 0.10307262569832402
Current ratio: 3.3204853675945754
Quick ratio: 2.780870806566738
COGS to revenue (%): 75.59523809523809
R&D to revenue (%): 140.7312925170068
SG&A to revenue (%): 584.7789115646259
Free cash flow (dilution-adjusted): -8900000
Buyback yield (%): 0
Retained earnings: -37886000
Inventory turnover: 1.1759259259259258
Receivables turnover: 6.758620689655173
Capitalized R&D asset: 2814100
ROCI (R&D-adjusted, %): -117.47664926459768
Rosenberg metric: -0.006936416184971098
FCF margin (%): -756.8027210884353
Revenue growth (%): -36.08695652173913
Rule of 40 score: -792.8896776101744
Financial ratios for VBIO — quarterly report dated 2024-09-30
Gross profit: 44000
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.25
Shares outstanding: 3200824
Market cap (USD): 13603502
Buyback yield (%): 0
Inventory turnover: 0.1704781704781705
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VBIO — annual report dated 2024-12-31
Total revenue: 0
Gross profit: 2000
Operating income: -4476000
Net income: -5655000
Capital expenditures: 0
Operating cash flow: -5725000
Depreciation & amortization: 352000
Net tangible assets: 2535000
Owner earnings: -5303000
Return on net tangible assets (%): -209.1913214990138
Buffett classification: The Gruesome
Stock price: 5.88
Shares outstanding: 3200824
Book value: 2535000
P/B ratio: 7.42439649704142
Market cap (USD): 18820845.12
Debt to equity: 0
Current ratio: 9.702205882352942
Quick ratio: 8.011029411764707
Free cash flow (dilution-adjusted): -5954000
Buyback yield (%): 0
Retained earnings: -43541000
Inventory turnover: 1.691304347826087
Receivables turnover: 0
Capitalized R&D asset: 2992750
ROCI (R&D-adjusted, %): -85.5501786441138
Rosenberg metric: -0.17220543806646527
Revenue growth (%): -100
Rule of 40 score: -100
Financial ratios for VBIO — quarterly report dated 2024-12-31
Gross profit: -239000
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.88
Shares outstanding: 3200824
Market cap (USD): 18820845.12
Buyback yield (%): 0
Inventory turnover: 0.9108695652173913
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VBIO — quarterly report dated 2025-03-31
Total revenue: 0
Gross profit: 50000
Operating income: -1377000
Net income: -1502000
Capital expenditures: 0
Operating cash flow: -889000
Depreciation & amortization: 1000
Net tangible assets: 810000
Owner earnings: -1501000
Return on net tangible assets (%): -185.30864197530866
Buffett classification: The Gruesome
Stock price: 2.56
Shares outstanding: 3200824
Book value: 3036000
P/B ratio: 2.6989820289855073
Market cap (USD): 8194109.44
Debt to equity: 0
Current ratio: 1.7017543859649122
Quick ratio: 1.0796221322537112
Free cash flow (dilution-adjusted): -1515000
Buyback yield (%): 0
Retained earnings: -45043000
Inventory turnover: 0.04338394793926247
Receivables turnover: 0
Capitalized R&D asset: 335000
ROCI (R&D-adjusted, %): -34.223276970236334
Rule of 40 score: 0
Financial ratios for VBIO — quarterly report dated 2025-06-30
Total revenue: 94000
Gross profit: 54000
Operating income: -1934000
Net income: -1931000
Capital expenditures: 3000
Operating cash flow: -1827000
Depreciation & amortization: 1000
Net tangible assets: 1444000
Owner earnings: -1933000
Return on net tangible assets (%): -133.86426592797784
Buffett classification: The Gruesome
Stock price: 4.15
Shares outstanding: 3200824
Book value: 3687000
P/B ratio: 3.602771792785463
Market cap (USD): 13283419.600000001
Debt to equity: 0
Current ratio: 2.243605359317905
Quick ratio: 1.6833130328867234
COGS to revenue (%): 34.04255319148936
R&D to revenue (%): 696.8085106382978
SG&A to revenue (%): 1418.0851063829787
Free cash flow (dilution-adjusted): -2023000
Buyback yield (%): 0
Retained earnings: -46975000
Inventory turnover: 0.06956521739130435
Receivables turnover: 7.230769230769231
Capitalized R&D asset: 879450
ROCI (R&D-adjusted, %): -35.235248387697226
Rosenberg metric: 0.011940298507462687
FCF margin (%): -2152.127659574468
Rule of 40 score: -2152.127659574468
Financial ratios for VBIO — quarterly report dated 2025-09-30
Total revenue: 161000
Gross profit: -145000
Operating income: -2483000
Net income: -2596000
Capital expenditures: 10000
Operating cash flow: -1996000
Depreciation & amortization: 0
Net tangible assets: 3348000
Owner earnings: -2606000
Return on net tangible assets (%): -77.83751493428913
Buffett classification: The Gruesome
Stock price: 2.89
Shares outstanding: 3200824
Book value: 5591000
P/B ratio: 1.6545128527991415
Market cap (USD): 9250381.360000001
Debt to equity: 0
Current ratio: 5.862068965517241
Quick ratio: 5.144200626959248
COGS to revenue (%): 180.74534161490683
R&D to revenue (%): 532.9192546583851
SG&A to revenue (%): 919.2546583850932
Free cash flow (dilution-adjusted): -2145000
Buyback yield (%): 0
Retained earnings: -49617000
Inventory turnover: 0.6353711790393013
Receivables turnover: 8.473684210526315
Capitalized R&D asset: 1407400
ROCI (R&D-adjusted, %): -32.0216049382716
Rosenberg metric: -0.30381679389312977
FCF margin (%): -1332.2981366459628
Revenue growth (%): 71.27659574468085
Rule of 40 score: -1261.021540901282
Financial ratios for VBIO — quarterly report dated 2025-12-31
Total revenue: -302000
Operating income: -1975000
Net income: -2802000
Capital expenditures: 25000
Operating cash flow: -2287000
Depreciation & amortization: 3000
Net tangible assets: 14554000
Owner earnings: -2824000
Return on net tangible assets (%): -19.403600384773945
Buffett classification: The Gruesome
Stock price: 1.45
Shares outstanding: 3200824
Book value: 16797000
P/B ratio: 0.27631093647675176
Market cap (USD): 4641194.8
Debt to equity: 0.3842352801095434
Current ratio: 20.13312693498452
Quick ratio: 20.13312693498452
Free cash flow (dilution-adjusted): -2461000
Buyback yield (%): 0
Retained earnings: -52597000
Capitalized R&D asset: 2074010
ROCI (R&D-adjusted, %): -4.915996695626852
Revenue growth (%): -287.5776397515528
Rule of 40 score: -287.5776397515528
Financial ratios for VBIO — annual report dated 2025-12-31
Total revenue: 0
Operating income: -7898000
Net income: -8878000
Capital expenditures: 38000
Operating cash flow: -6999000
Depreciation & amortization: 5000
Net tangible assets: 14554000
Owner earnings: -8911000
Return on net tangible assets (%): -61.22715404699739
Buffett classification: The Gruesome
Stock price: 1.45
Shares outstanding: 3200824
Book value: 16797000
P/B ratio: 0.27631093647675176
Market cap (USD): 4641194.8
Debt to equity: 0.3842352801095434
Current ratio: 20.13312693498452
Quick ratio: 20.13312693498452
Interest coverage ratio: -54.0958904109589
Free cash flow (dilution-adjusted): -8144000
Buyback yield (%): 0
Retained earnings: -52597000
Capitalized R&D asset: 4556860
ROCI (R&D-adjusted, %): -19.145297605204817
Rule of 40 score: 0
Financial ratios for VIVIDHA.NS — annual report dated 2022-03-31
Capital expenditures: 5024.396676777002
Buffett classification: The Gruesome
Stock price: 0.02175919820651457
Shares outstanding: 292700534
Market cap (USD): 6368928.934458657
Buyback yield (%): 0
Retained earnings: -1419741.5271000923
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VIVIDHA.NS — annual report dated 2023-03-31
Total revenue: 95992.69183922047
Gross profit: 28489.646772228993
Operating income: -102521.31546894033
Net income: -169951.27892813642
Capital expenditures: 133.98294762484775
Operating cash flow: -47417.78319123021
Depreciation & amortization: 79098.66017052376
Net tangible assets: 2232095.006090134
Owner earnings: -90986.60170523751
Return on net tangible assets (%): -4.0762871408692805
Buffett classification: The Gruesome
Stock price: 0.009744214372716201
Shares outstanding: 292700534
Book value: 2232265.529841657
P/B ratio: 1.2776870458178962
Market cap (USD): 2852136.750304507
Debt to equity: 0.45891558310461666
Current ratio: 35.64997674779104
Quick ratio: 19.11068051464889
Interest coverage ratio: -1.2143990766123214
COGS to revenue (%): 70.3210252506027
SG&A to revenue (%): 14.262149473417079
Free cash flow (dilution-adjusted): -47551.766138855055
Buyback yield (%): 0
Retained earnings: -1481266.7478684532
Inventory turnover: 0.05194245278597872
Receivables turnover: 0.07331844822774211
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.1480366379552165
FCF margin (%): -49.536860804466436
Rule of 40 score: -49.536860804466436
Financial ratios for VIVIDHA.NS — annual report dated 2024-03-31
Total revenue: 984602.4703201823
Gross profit: -890442.4991006115
Operating income: -1035651.7568053723
Net income: -1862693.3685094137
Capital expenditures: 22376.783787024822
Operating cash flow: 141156.01391054085
Depreciation & amortization: 78762.44153975297
Net tangible assets: 335040.1726825758
Owner earnings: -1806307.7107566856
Return on net tangible assets (%): -539.1316797308423
Buffett classification: The Gruesome
Stock price: 0.012595969289827256
Shares outstanding: 292700534
Book value: 335040.17268257577
P/B ratio: 11.00419364000578
Market cap (USD): 3686846.9373800387
Debt to equity: 2.3249221518307746
Current ratio: 84.32407407407408
Quick ratio: 58.210317460317455
Interest coverage ratio: -7.870500318964732
COGS to revenue (%): 190.4367524906828
SG&A to revenue (%): 1.0997978223272356
Free cash flow (dilution-adjusted): 141156.01391054085
Buyback yield (%): 0
Retained earnings: -3321045.6889315266
Inventory turnover: 7.920170195522237
Receivables turnover: 2.6287379138118716
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -92.96840518865386
FCF margin (%): 14.336345699461672
Revenue growth (%): 925.705656811153
Rule of 40 score: 940.0420025106146
Financial ratios for VIVIDHA.NS — annual report dated 2025-03-31
Total revenue: 0
Gross profit: 0
Operating income: -151262.56722001403
Net income: -194528.87537993919
Capital expenditures: 31049.801262567216
Operating cash flow: 89817.6291793313
Depreciation & amortization: 75263.03483750291
Net tangible assets: 132090.25017535654
Owner earnings: -150315.64180500348
Return on net tangible assets (%): -113.7976812107266
Buffett classification: The Gruesome
Stock price: 0.01015287664838371
Shares outstanding: 292700534
Book value: 132090.25017535652
P/B ratio: 22.497893770909585
Market cap (USD): 2971752.416618042
Debt to equity: 5.620762899371628
Interest coverage ratio: -2.5749253731343287
Free cash flow (dilution-adjusted): 58767.82791676408
Buyback yield (%): 0
Retained earnings: -3432101.9406125788
Inventory turnover: 0
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -17.2962784728906
Revenue growth (%): -100
Rule of 40 score: -100
Financial ratios for VIVIDHA.NS — quarterly report dated 2025-03-31
Total revenue: 0
Gross profit: 0
Operating income: -60953.93967734393
Net income: -58124.853869534716
Capital expenditures: 0
Depreciation & amortization: 47322.88987608136
Net tangible assets: 132090.25017535654
Owner earnings: -10801.963993453355
Return on net tangible assets (%): -8.17771484202142
Buffett classification: The Gruesome
Stock price: 0.01015287664838371
Shares outstanding: 292700534
Book value: 132090.25017535652
P/B ratio: 22.497893770909585
Market cap (USD): 2971752.416618042
Debt to equity: 5.620762899371628
Interest coverage ratio: -4.818853974121996
Buyback yield (%): 0
Retained earnings: -3432101.9406125788
Inventory turnover: 0
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.969842797561758
Rule of 40 score: 0
Financial ratios for VIVIDHA.NS — quarterly report dated 2025-06-30
Total revenue: 12695.99812777908
Gross profit: 2410.4844371635854
Operating income: -59840.86122162415
Net income: -69763.63210858882
Capital expenditures: 0
Depreciation & amortization: 16007.488883688276
Owner earnings: -53756.143224900545
Buffett classification: The Gruesome
Stock price: 0.009946173648490523
Shares outstanding: 292700534
Market cap (USD): 2911250.3381699044
Interest coverage ratio: -6.0306603773584895
COGS to revenue (%): 81.01382488479261
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VIVIDHA.NS — quarterly report dated 2025-09-30
Total revenue: 0
Gross profit: 0
Operating income: -26358.511837655016
Net income: -33810.597519729425
Capital expenditures: 0
Depreciation & amortization: 14475.76099210823
Net tangible assets: 26369.78579481398
Owner earnings: -19334.836527621195
Return on net tangible assets (%): -73.32193244976486
Buffett classification: The Gruesome
Stock price: 0.009244644870349492
Shares outstanding: 292700534
Book value: 26369.785794814
P/B ratio: 102.614124788371
Market cap (USD): 2705912.490191657
Debt to equity: 26.226165027789634
Interest coverage ratio: -3.2929577464788733
Buyback yield (%): 0
Inventory turnover: 0
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.6713671053044816
Revenue growth (%): -100
Rule of 40 score: -100
Financial ratios for VIVIDHA.NS — quarterly report dated 2025-12-31
Total revenue: 746.3517879024173
Gross profit: 746.3517879024173
Operating income: -17188.37027960343
Net income: -24228.58415951877
Capital expenditures: 0
Depreciation & amortization: 13434.332182243512
Owner earnings: -10794.251977275258
Buffett classification: The Gruesome
Stock price: 0.0070179347220675065
Shares outstanding: 292700534
Market cap (USD): 2054153.2407263007
Interest coverage ratio: -2.441455696202531
COGS to revenue (%): 0
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VODI.DE — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.2
Shares outstanding: 23027555926
Market cap (USD): 27633067111.2
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VODI.DE — annual report dated 2023-03-31
Total revenue: 46508641975.30864
Gross profit: 16435802469.135801
Operating income: 6466666666.666666
Net income: 15228395061.728394
Capital expenditures: 6008641975.308641
Operating cash flow: 22288888888.88889
Depreciation & amortization: 12660493827.160494
Net tangible assets: 19990123456.790123
Owner earnings: 21880246913.580246
Return on net tangible assets (%): 109.45528656126481
Capex to operating income (%): 92.91714394807178
Buffett classification: The Gruesome
Stock price: 0.8586956521739131
P/E ratio: 1.2984731531914666
Shares outstanding: 23027555926
Book value: 79608641975.30862
P/B ratio: 0.24838587448810917
Market cap (USD): 19773662153.847828
Debt to equity: 1.0295736860878062
Current ratio: 0.9413895796874521
Quick ratio: 0.9120383162936355
Effective tax rate (%): 3.763194125745755
Interest coverage ratio: 2.13100081366965
COGS to revenue (%): 64.66075599915055
SG&A to revenue (%): 21.575706094712256
Free cash flow (dilution-adjusted): 12641975308.641975
Buyback yield (%): 11.656607934693634
Retained earnings: -139612345679.01233
Inventory turnover: 25.48012552301255
Receivables turnover: 3.5191032227930874
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.260268401789345
FCF margin (%): 27.18199193034615
Rule of 40 score: 27.18199193034615
Financial ratios for VODI.DE — annual report dated 2024-03-31
Total revenue: 46477215189.87341
Gross profit: 15516455696.202532
Operating income: 4830379746.835443
Net income: 1905063291.1392405
Capital expenditures: 5321518987.341772
Operating cash flow: 20958227848.101265
Depreciation & amortization: 13182278481.012657
Net tangible assets: 26726582278.48101
Owner earnings: 9765822784.810125
Return on net tangible assets (%): 36.5397366676139
Capex to operating income (%): 110.16771488469604
Buffett classification: The Gruesome
Stock price: 0.7717391304347825
P/E ratio: 9.328438624074389
Shares outstanding: 23027555926
Book value: 77212658227.8481
P/B ratio: 0.23016000736469974
Market cap (USD): 17771265986.369564
Debt to equity: 0.9342437456965803
Current ratio: 1.3515544926545953
Quick ratio: 1.3321489579774515
Effective tax rate (%): 3.08641975308642
Interest coverage ratio: 1.388646288209607
COGS to revenue (%): 66.61491951956859
SG&A to revenue (%): 22.992074515891822
Free cash flow (dilution-adjusted): 12150632911.392405
Buyback yield (%): 0
Retained earnings: -145115189873.41772
Inventory turnover: 43.061619718309856
Receivables turnover: 11.187385740402194
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.315954118873826
FCF margin (%): 26.143203420758777
Revenue growth (%): -0.06757192663658267
Rule of 40 score: 26.075631494122195
Financial ratios for VODI.DE — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 28226666666.666668
Buffett classification: The Gruesome
Stock price: 0.911111111111111
Shares outstanding: 23027555926
Book value: 80781333333.33333
P/B ratio: 0.2597216609354196
Market cap (USD): 20980662065.91111
Debt to equity: 0.92022909583072
Current ratio: 1.3653572937065621
Quick ratio: 1.3388242521982874
Buyback yield (%): 0
Retained earnings: -154260000000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VODI.DE — annual report dated 2025-03-31
Total revenue: 48633766233.766235
Gross profit: 16258441558.441559
Operating income: 5374025974.025974
Net income: -4864935064.935065
Capital expenditures: 5603896103.896104
Operating cash flow: 19964935064.935066
Depreciation & amortization: 14031168831.16883
Net tangible assets: 25074025974.025974
Owner earnings: 3562337662.337661
Capex to operating income (%): 104.2774287095215
Buffett classification: The Gruesome
Stock price: 0.8913043478260869
Shares outstanding: 23027555926
Book value: 70020779220.77924
P/B ratio: 0.29312099843872264
Market cap (USD): 20524560716.652172
Debt to equity: 0.9856628830031899
Current ratio: 1.2578008262283555
Quick ratio: 1.2306847147754243
Interest coverage ratio: 1.8085664335664338
COGS to revenue (%): 66.56964323862422
SG&A to revenue (%): 22.38036744285409
Free cash flow (dilution-adjusted): 11176623376.623377
Buyback yield (%): 11.819858458679521
Retained earnings: -160393506493.5065
Inventory turnover: 40.403565640194486
Receivables turnover: 10.240087503418104
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.9123734246031368
FCF margin (%): 22.981200598162786
Revenue growth (%): 4.640017770175477
Rule of 40 score: 27.621218368338262
Financial ratios for VODI.DE — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 25074025974.025974
Buffett classification: The Gruesome
Stock price: 0.8913043478260869
Shares outstanding: 23027555926
Book value: 70020779220.77924
P/B ratio: 0.29312099843872264
Market cap (USD): 20524560716.652172
Debt to equity: 0.9856628830031899
Current ratio: 1.2578008262283555
Quick ratio: 1.2306847147754243
Buyback yield (%): 0
Retained earnings: -160393506493.5065
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VODI.DE — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 22608108108.10811
Buffett classification: The Gruesome
Stock price: 1.1176470588235294
Shares outstanding: 23027555926
Book value: 76498648648.64865
P/B ratio: 0.3364331345354148
Market cap (USD): 25736680152.588238
Debt to equity: 0.9089544065431291
Current ratio: 1.166013734617689
Quick ratio: 1.1329216020648014
Buyback yield (%): 0
Retained earnings: -166704054054.05405
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for WELL.TO — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.866141732283465
Shares outstanding: 255408705
Market cap (USD): 987446253.1889764
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for WELL.TO — annual report dated 2022-12-31
Total revenue: 418482352.9411764
Gross profit: 223008088.2352941
Operating income: 17633823.529411763
Net income: 13731617.647058822
Capital expenditures: 4708823.529411765
Operating cash flow: 56283823.52941176
Depreciation & amortization: 40590441.176470585
Net tangible assets: -248686029.41176468
Owner earnings: 49613235.294117644
Return on net tangible assets (%): -19.950149757697073
Capex to operating income (%): 26.703360853973816
Buffett classification: The Good
Stock price: 2.0882352941176467
P/E ratio: 38.84127026506024
Shares outstanding: 255408705
Book value: 599449264.7058823
P/B ratio: 0.8897391382531269
Market cap (USD): 533353472.20588225
Debt to equity: 0.43963883515628926
Current ratio: 1.3864313019186945
Quick ratio: 1.3738421671690069
Effective tax rate (%): -6.562054208273895
Interest coverage ratio: 0.968265503875969
COGS to revenue (%): 46.710276629838916
SG&A to revenue (%): 39.3765286328751
Free cash flow (dilution-adjusted): 33572794.11764706
Buyback yield (%): 0.03350057324071634
Retained earnings: -46813235.294117644
Inventory turnover: 194.04744525547446
Receivables turnover: 7.160564656148561
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.981644462476254
FCF margin (%): 8.022511315397375
Rule of 40 score: 8.022511315397375
Financial ratios for WELL.TO — annual report dated 2023-12-31
Total revenue: 587919696.969697
Gross profit: 282020454.54545456
Operating income: 26152272.727272727
Net income: 12603787.878787879
Capital expenditures: 6141666.666666666
Operating cash flow: 50331060.6060606
Depreciation & amortization: 46036363.63636363
Net tangible assets: -223935606.06060606
Owner earnings: 52498484.84848485
Return on net tangible assets (%): -23.44356298313571
Capex to operating income (%): 23.484255960140203
Buffett classification: The Great
Stock price: 2.9166666666666665
P/E ratio: 59.10461707339063
Shares outstanding: 255408705
Book value: 641019696.969697
P/B ratio: 1.1621203837753766
Market cap (USD): 744942056.25
Debt to equity: 0.5037936715413178
Current ratio: 1.5211928353987185
Quick ratio: 1.5110168249122535
Effective tax rate (%): 14.668923424116532
Interest coverage ratio: 1.0580500812210745
COGS to revenue (%): 52.03078651743307
SG&A to revenue (%): 35.690557615836006
Free cash flow (dilution-adjusted): 24369696.96969697
Buyback yield (%): 0
Retained earnings: -48169696.96969697
Inventory turnover: 342.19237288135594
Receivables turnover: 7.041593321840124
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.6691295348565696
FCF margin (%): 4.1450723789839365
Revenue growth (%): 40.488527852532265
Rule of 40 score: 44.6336002315162
Financial ratios for WELL.TO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.281481481481481
Shares outstanding: 255408705
Market cap (USD): 838118935.6666666
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for WELL.TO — quarterly report dated 2024-12-31
Total revenue: 135132867.13286713
Gross profit: 28781818.181818184
Operating income: -45055244.755244754
Net income: -9093006.993006993
Capital expenditures: 4168531.468531469
Operating cash flow: -71741258.74125874
Depreciation & amortization: 14659440.55944056
Net tangible assets: -189840559.44055945
Owner earnings: 1397902.0979020987
Buffett classification: The Gruesome
Stock price: 4.7972027972027975
Shares outstanding: 255408705
Book value: 650154545.4545455
P/B ratio: 1.8845478550016619
Market cap (USD): 1225247354.0559442
Debt to equity: 0.45722211287042025
Current ratio: 0.905874747432448
Quick ratio: 0.8988316460599461
COGS to revenue (%): 78.70109708134963
SG&A to revenue (%): 43.79217553301594
Free cash flow (dilution-adjusted): -77928671.32867134
Buyback yield (%): 0.03458699358732705
Retained earnings: -21660839.160839163
Inventory turnover: 56.51505016722408
Receivables turnover: 0.9676078694500498
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.520708365229509
FCF margin (%): -57.66818464086111
Rule of 40 score: -57.66818464086111
Financial ratios for WELL.TO — annual report dated 2024-12-31
Total revenue: 643138461.5384616
Gross profit: 253853846.15384617
Operating income: -21513986.013986014
Net income: 22803496.503496505
Capital expenditures: 11346853.146853147
Operating cash flow: 6658741.258741259
Depreciation & amortization: 50563636.36363637
Net tangible assets: -189840559.44055945
Owner earnings: 62020279.72027972
Return on net tangible assets (%): -32.6696675900277
Buffett classification: The Gruesome
Stock price: 4.7972027972027975
P/E ratio: 53.7306791468613
Shares outstanding: 255408705
Book value: 650154545.4545455
P/B ratio: 1.8845478550016619
Market cap (USD): 1225247354.0559442
Debt to equity: 0.45722211287042025
Current ratio: 0.905874747432448
Quick ratio: 0.8988316460599461
Effective tax rate (%): -223.57651245551602
Interest coverage ratio: -0.8489238410596026
COGS to revenue (%): 60.52889675629126
SG&A to revenue (%): 34.954245352771814
Free cash flow (dilution-adjusted): -15366433.566433568
Buyback yield (%): 0.09462910126697731
Retained earnings: -21660839.160839163
Inventory turnover: 206.86622073578596
Receivables turnover: 4.605140479397524
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.15864894467221
FCF margin (%): -2.389288541331408
Revenue growth (%): 9.392229049881738
Rule of 40 score: 7.0029405085503305
Financial ratios for WELL.TO — quarterly report dated 2025-03-31
Total revenue: 205690209.7902098
Gross profit: 82148251.74825175
Operating income: 5403496.503496503
Net income: -29290909.090909094
Capital expenditures: 3806993.0069930074
Operating cash flow: 14914685.314685315
Depreciation & amortization: 13668531.468531469
Net tangible assets: -240382517.48251748
Owner earnings: -19429370.629370634
Capex to operating income (%): 70.45425132651741
Buffett classification: The Good
Stock price: 2.895104895104895
Shares outstanding: 255408705
Book value: 637055244.7552449
P/B ratio: 1.160707800752808
Market cap (USD): 739434992.097902
Debt to equity: 0.5205781848079395
Current ratio: 0.9243969107353865
Quick ratio: 0.915821103394956
Interest coverage ratio: 0.6971939005684381
COGS to revenue (%): 60.06214791066748
SG&A to revenue (%): 30.665642200743193
Free cash flow (dilution-adjusted): 9383916.083916085
Buyback yield (%): 0.026763961675740584
Retained earnings: -54230069.93006993
Inventory turnover: 56.47858056265985
Receivables turnover: 1.5186829754387414
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.5339209434929637
FCF margin (%): 4.56215980988451
Revenue growth (%): 52.21330987373216
Rule of 40 score: 56.77546968361667
Financial ratios for WELL.TO — quarterly report dated 2025-06-30
Total revenue: 260345255.47445253
Gross profit: 115867883.21167882
Operating income: 19055474.452554744
Net income: 12407299.270072991
Capital expenditures: 4336496.3503649635
Operating cash flow: 19933576.642335765
Depreciation & amortization: 18536496.35036496
Net tangible assets: -478588321.16788316
Owner earnings: 26607299.270072985
Return on net tangible assets (%): -5.5595379354732435
Capex to operating income (%): 22.75722056232284
Buffett classification: The Great
Stock price: 2.9635036496350358
P/E ratio: 15.251196351041296
Shares outstanding: 255408705
Book value: 719303649.6350365
P/B ratio: 1.0522741401355322
Market cap (USD): 756904629.4160582
Debt to equity: 0.5781777996967871
Current ratio: 0.9284983752573048
Quick ratio: 0.921108708879769
Effective tax rate (%): 25.840931896514114
Interest coverage ratio: 2.0735504368546467
COGS to revenue (%): 55.49452860182858
SG&A to revenue (%): 30.066195086255476
Free cash flow (dilution-adjusted): 11352554.744525548
Buyback yield (%): 0.009064964860773213
Retained earnings: -47735766.42335766
Inventory turnover: 69.3531885073581
Receivables turnover: 1.6762367117519337
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.5987839785995912
FCF margin (%): 4.360576774804934
Revenue growth (%): 26.571534804688664
Rule of 40 score: 30.932111579493597
Financial ratios for WELL.TO — quarterly report dated 2025-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.697841726618705
Shares outstanding: 255408705
Market cap (USD): 944460966.6906475
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for WELL.TO — annual report dated 2025-12-31
Total revenue: 1022028467.1532845
Gross profit: 451710948.90510947
Operating income: 67667883.21167883
Net income: 3256934.306569343
Capital expenditures: 20343065.693430655
Operating cash flow: 88969343.06569342
Depreciation & amortization: 68439416.05839415
Net tangible assets: -499502919.70802915
Owner earnings: 51353284.67153283
Return on net tangible assets (%): -10.280877777761539
Capex to operating income (%): 30.063103392481523
Buffett classification: The Good
Stock price: 2.9124087591240877
P/E ratio: 228.39102038323622
Shares outstanding: 255408705
Book value: 758684671.5328467
P/B ratio: 0.9804528515063528
Market cap (USD): 743854549.5985402
Debt to equity: 0.5778787336515945
Current ratio: 1.0339584743723877
Quick ratio: 1.0270627136566834
Effective tax rate (%): 15.93820648078372
Interest coverage ratio: 1.6414356032437412
COGS to revenue (%): 55.802508107891924
SG&A to revenue (%): 30.880123184250014
Free cash flow (dilution-adjusted): 52063503.649635024
Buyback yield (%): 0.1791810934070118
Retained earnings: -27981751.824817516
Inventory turnover: 316.97160243407706
Receivables turnover: 6.910198642813079
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.329643985185884
FCF margin (%): 5.094134392816918
Revenue growth (%): 58.91266473295257
Rule of 40 score: 64.00679912576949
Financial ratios for WELL.TO — quarterly report dated 2025-12-31
Total revenue: 280854014.5985401
Gross profit: 129096350.36496349
Operating income: 21556204.379562043
Net income: 23359854.014598537
Capital expenditures: 6189781.02189781
Operating cash flow: 33609489.05109489
Depreciation & amortization: 16278102.189781021
Net tangible assets: -499502919.70802915
Owner earnings: 33448175.18248175
Return on net tangible assets (%): -6.696292226286279
Capex to operating income (%): 28.71461465528918
Buffett classification: The Good
Stock price: 2.9124087591240877
P/E ratio: 114.85894097615721
Shares outstanding: 255408705
Book value: 758684671.5328467
P/B ratio: 0.9804528515063528
Market cap (USD): 743854549.5985402
Debt to equity: 0.5778787336515945
Current ratio: 1.0339584743723877
Quick ratio: 1.0270627136566834
Effective tax rate (%): -72.12391760339914
Interest coverage ratio: 1.7479727730097663
COGS to revenue (%): 54.03435818800841
SG&A to revenue (%): 32.4944772201575
Free cash flow (dilution-adjusted): 21243065.693430655
Buyback yield (%): 0.06898373968517485
Retained earnings: -27981751.824817516
Inventory turnover: 84.34401622718052
Receivables turnover: 1.8989265885256017
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.6978053629309047
FCF margin (%): 7.563739376770538
Rule of 40 score: 7.563739376770538
Financial ratios for WISE.L — annual report dated 2022-03-31
Total revenue: 974479626.5
Gross profit: 637957485.1710527
Operating income: 84173745.67105263
Net income: 56864809.71052632
Capital expenditures: 7950702.881578947
Operating cash flow: 5423762092.842105
Depreciation & amortization: 39580673.01315789
Net tangible assets: 672180075.8157895
Owner earnings: 88494779.84210525
Return on net tangible assets (%): 13.165338132747213
Capex to operating income (%): 9.445585221608114
Buffett classification: The Great
Stock price: 0.06513157894736843
P/E ratio: 1.131018047981371
Shares outstanding: 987464562
Book value: 707266873.2894745
P/B ratio: 0.09093473553837478
Market cap (USD): 64315126.077631585
Debt to equity: 0.2338709677380344
Current ratio: 1.049243606845992
Quick ratio: 1.049243606845992
Effective tax rate (%): 25.056947604368844
Interest coverage ratio: 11.068181815311329
COGS to revenue (%): 34.53352252602968
R&D to revenue (%): 3.37562078750194
SG&A to revenue (%): 52.94430649081784
Free cash flow (dilution-adjusted): 5330254913.355264
Buyback yield (%): 0
Retained earnings: 388028868.65789473
Receivables turnover: 5.473786407682318
Capitalized R&D asset: 32894736.842105262
ROCI (R&D-adjusted, %): 11.435209138180193
FCF margin (%): 546.9847463614739
Rule of 40 score: 546.9847463614739
Financial ratios for WISE.L — annual report dated 2023-03-31
Total revenue: 1508080455.0123456
Gross profit: 975825759.2962962
Operating income: 236081944.90123457
Net income: 174309208.02469134
Capital expenditures: 5504501.308641975
Operating cash flow: 5993637408.098765
Depreciation & amortization: 35473452.86419753
Net tangible assets: 864665413.4691358
Owner earnings: 204278159.5802469
Return on net tangible assets (%): 23.62511052230709
Capex to operating income (%): 2.3316062187410376
Buffett classification: The Great
Stock price: 0.0671604938271605
P/E ratio: 0.3804653143243387
Shares outstanding: 987464562
Book value: 882096334.2839508
P/B ratio: 0.07518295342942949
Market cap (USD): 66318607.62074074
Debt to equity: 0.4583116657957754
Current ratio: 1.0402799929109616
Quick ratio: 1.0402799929109616
Effective tax rate (%): 22.18430034110882
Interest coverage ratio: 15.43999999809449
COGS to revenue (%): 35.29352124066167
R&D to revenue (%): 3.4955727466333686
SG&A to revenue (%): 47.78464970133679
Free cash flow (dilution-adjusted): 5891192522.691358
Buyback yield (%): 23.286351713742043
Retained earnings: 547086268.6790123
Receivables turnover: 5.1236363637082025
Capitalized R&D asset: 74755523.06692657
ROCI (R&D-adjusted, %): 25.515772739608572
Rosenberg metric: 10.271195533407404
FCF margin (%): 390.64179255894743
Revenue growth (%): 54.75751508821776
Rule of 40 score: 445.3993076471652
Financial ratios for WISE.L — annual report dated 2024-03-31
Total revenue: 2456598809.227848
Gross profit: 1745764077.0253162
Operating income: 770603659.772152
Net income: 566686142.1772151
Capital expenditures: 16939856.481012657
Operating cash flow: 5192066010.468354
Depreciation & amortization: 29245223.92405063
Net tangible assets: 1555590216.5569618
Owner earnings: 578991509.620253
Return on net tangible assets (%): 37.22005342137942
Capex to operating income (%): 2.1982579846585915
Buffett classification: The Great
Stock price: 0.11759493670886075
P/E ratio: 0.20491207394713276
Shares outstanding: 987464562
Book value: 1565977864.4050674
P/B ratio: 0.07415228229598794
Market cap (USD): 116120832.6706329
Debt to equity: 0.22879885702755381
Current ratio: 1.0771806040539313
Quick ratio: 1.0771806040539313
Effective tax rate (%): 26.33984212806023
Interest coverage ratio: 23.753694582341794
COGS to revenue (%): 28.93572729630849
SG&A to revenue (%): 38.875878220040356
Free cash flow (dilution-adjusted): 5055428488.873418
Buyback yield (%): 94.13471705678327
Retained earnings: 1187228243.1518986
Receivables turnover: 3.924431963237362
Capitalized R&D asset: 46175016.24431449
ROCI (R&D-adjusted, %): 36.3679120601964
Rosenberg metric: 14.605387291815134
FCF margin (%): 205.7897475926249
Revenue growth (%): 62.8957394854466
Rule of 40 score: 268.6854870780715
Financial ratios for WISE.L — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 1557333333.3333333
Buffett classification: The Gruesome
Stock price: 0.0896
Shares outstanding: 987464562
Book value: 1564800000
P/B ratio: 0.05654193811042945
Market cap (USD): 88476824.7552
Debt to equity: 0.04464894342194956
Current ratio: 1.0714571512905449
Quick ratio: 1.0714571512905449
Buyback yield (%): 0
Retained earnings: 1293866666.6666667
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for WISE.L — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 2322295736.012987
Buffett classification: The Gruesome
Stock price: 0.12272727272727271
Shares outstanding: 987464562
Book value: 2329016314.0259743
P/B ratio: 0.052034342515876145
Market cap (USD): 121188832.6090909
Debt to equity: 0.13389121338814142
Current ratio: 1.0782158724033706
Quick ratio: 1.0782158724033706
Buyback yield (%): 0
Retained earnings: 1961904739.5064936
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for WISE.L — annual report dated 2025-03-31
Total revenue: 3034677006.4935064
Gross profit: 2197292984.7792206
Operating income: 937184605.3766234
Net income: 700116215.5974026
Capital expenditures: 57964985.454545446
Operating cash flow: 7551241467.181817
Depreciation & amortization: 30914658.909090906
Net tangible assets: 2322295736.012987
Owner earnings: 673065889.051948
Return on net tangible assets (%): 28.982781073675618
Capex to operating income (%): 6.185012549502052
Buffett classification: The Great
Stock price: 0.12272727272727271
P/E ratio: 0.17309816557481333
Shares outstanding: 987464562
Book value: 2329016314.0259743
P/B ratio: 0.052034342515876145
Market cap (USD): 121188832.6090909
Debt to equity: 0.13389121338814142
Current ratio: 1.0782158724033706
Quick ratio: 1.0782158724033706
Effective tax rate (%): 26.22167138883715
Interest coverage ratio: 36.220779221972116
COGS to revenue (%): 27.599379913896954
SG&A to revenue (%): 40.89801793814643
Free cash flow (dilution-adjusted): 7393643912.51948
Buyback yield (%): 100.65159347093176
Retained earnings: 1961904739.5064936
Receivables turnover: 5.811454311390824
Capitalized R&D asset: 17396296.296296295
ROCI (R&D-adjusted, %): 33.53285395626442
FCF margin (%): 243.63857823085598
Revenue growth (%): 23.53164851721794
Rule of 40 score: 267.1702267480739
Financial ratios for WISE.L — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 2593354026.418919
Buffett classification: The Gruesome
Stock price: 0.13986486486486485
Shares outstanding: 987464562
Book value: 2600980470.1351395
P/B ratio: 0.05309982105163484
Market cap (USD): 138111597.52297297
Debt to equity: 0.2103462719927662
Current ratio: 1.0753536586567862
Quick ratio: 1.0753536586567862
Buyback yield (%): 0
Retained earnings: 2437011930.2972975
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for XLS.SW — annual report dated 2022-12-31
Total revenue: 1117360.8695652173
Gross profit: 201790.21739130435
Operating income: -22807520.65217391
Net income: 15556552.173913043
Capital expenditures: 16665.217391304348
Operating cash flow: -5008125
Depreciation & amortization: 17415565.217391305
Net tangible assets: -71385927.17391305
Owner earnings: 32955452.173913043
Return on net tangible assets (%): -46.16519456786734
Buffett classification: The Gruesome
Stock price: 32.28260869565217
P/E ratio: 11.968736254568533
Shares outstanding: 5767572
Book value: 367069268.4782609
P/B ratio: 0.5072401478115757
Market cap (USD): 186192270
Debt to equity: 0.17869429080952962
Current ratio: 0.6453011536299317
Quick ratio: 0.6453011536299317
Effective tax rate (%): -117.33917440189829
Interest coverage ratio: -30.52180812919198
COGS to revenue (%): 81.94046141334589
R&D to revenue (%): 14.078496301455681
SG&A to revenue (%): 169.1986746720728
Free cash flow (dilution-adjusted): -5095251.0869565215
Buyback yield (%): 0
Retained earnings: 96513463.04347825
Receivables turnover: 1.8854571899686543
Capitalized R&D asset: 157307.60869565216
ROCI (R&D-adjusted, %): -4.276107552816158
FCF margin (%): -456.0076539049702
Rule of 40 score: -456.0076539049702
Financial ratios for XLS.SW — annual report dated 2023-12-31
Total revenue: 1176708.3333333335
Gross profit: 534547.619047619
Operating income: -24176119.04761905
Net income: 17713448.80952381
Capital expenditures: 16551.190476190477
Operating cash flow: 204504.76190476192
Depreciation & amortization: 19083817.85714286
Net tangible assets: -20113439.285714287
Owner earnings: 36780715.47619048
Return on net tangible assets (%): -182.86636588459658
Buffett classification: The Gruesome
Stock price: 59.404761904761905
P/E ratio: 19.3424355196351
Shares outstanding: 5767572
Book value: 434567733.3333334
P/B ratio: 0.7884185022217588
Market cap (USD): 342621241.4285714
Debt to equity: 0.15484235325077933
Current ratio: 3.106950769420188
Quick ratio: 3.106950769420188
Effective tax rate (%): -104.53023290898358
Interest coverage ratio: -52.7436492126608
COGS to revenue (%): 54.572632494802384
R&D to revenue (%): 25.384673751941193
SG&A to revenue (%): 201.87265728146008
Free cash flow (dilution-adjusted): 155595.2380952381
Buyback yield (%): 0
Receivables turnover: 0.10829585458717612
Capitalized R&D asset: 404099.6692546584
ROCI (R&D-adjusted, %): -3.985124350526818
Rosenberg metric: 2.1153293500259776
FCF margin (%): 13.222923105717625
Revenue growth (%): 5.31139628965253
Rule of 40 score: 18.534319395370154
Financial ratios for XLS.SW — annual report dated 2024-12-31
Total revenue: 927641.1111111111
Gross profit: 610581.1111111111
Operating income: -21495992.22222222
Net income: 38085377.777777776
Capital expenditures: 13432.222222222223
Operating cash flow: -468344.44444444444
Depreciation & amortization: 17846311.111111112
Net tangible assets: 40069057.777777776
Owner earnings: 55918256.666666664
Return on net tangible assets (%): 139.55470821597115
Buffett classification: The Gruesome
Stock price: 28.22222222222222
P/E ratio: 4.273915821878563
Shares outstanding: 5767572
Book value: 440580568.88888884
P/B ratio: 0.3694527406807107
Market cap (USD): 162773698.66666666
Debt to equity: 0.14941880777755187
Current ratio: 1.534574323326102
Quick ratio: 1.5296753546333661
Effective tax rate (%): -19.774142434238016
Interest coverage ratio: -40.88651085332426
COGS to revenue (%): 34.179166511953255
R&D to revenue (%): 1.866023378294048
SG&A to revenue (%): 233.47666782052926
Free cash flow (dilution-adjusted): -481776.6666666666
Buyback yield (%): 0
Retained earnings: 38085377.777777776
Inventory turnover: 6.290456980358442
Receivables turnover: 0.0986379110351087
Capitalized R&D asset: 269352.9037267081
ROCI (R&D-adjusted, %): -3.664746915954427
Rosenberg metric: 0.2545449714573428
FCF margin (%): -51.935674356821416
Revenue growth (%): -21.16643650484521
Rule of 40 score: -73.10211086166663
Financial ratios for XLS.SW — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 40069057.777777776
Buffett classification: The Gruesome
Stock price: 28.22222222222222
Shares outstanding: 5767572
Book value: 440580568.88888884
P/B ratio: 0.3694527406807107
Market cap (USD): 162773698.66666666
Debt to equity: 0.14941880777755187
Current ratio: 1.534574323326102
Quick ratio: 1.5296753546333661
Buyback yield (%): 0
Retained earnings: 38085377.777777776
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for XLS.SW — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 52695785
Buffett classification: The Gruesome
Stock price: 24.937499999999996
Shares outstanding: 5767572
Book value: 489871401.25
P/B ratio: 0.2936052735125859
Market cap (USD): 143828826.74999997
Debt to equity: 0.15071842285873796
Current ratio: 1.0786893799703035
Quick ratio: 1.0749303132492545
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for XNCR — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 40.12
Shares outstanding: 74141596
Market cap (USD): 2974560831.52
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for XNCR — annual report dated 2022-12-31
Total revenue: 164579000
Operating income: -82473000
Net income: -55181000
Capital expenditures: 38494000
Operating cash flow: 24485000
Depreciation & amortization: 8799000
Net tangible assets: 708996000
Owner earnings: -84876000
Return on net tangible assets (%): -11.971294619433678
Buffett classification: The Gruesome
Stock price: 26.04
Shares outstanding: 74141596
Book value: 727496000
P/B ratio: 2.6538251204680163
Market cap (USD): 1930647159.84
Debt to equity: 0.0819715847234899
Current ratio: 10.578002631414071
Quick ratio: 10.578002631414071
Interest coverage ratio: -6344.076923076923
COGS to revenue (%): 0
R&D to revenue (%): 121.25666093487017
SG&A to revenue (%): 28.854835671622748
Free cash flow (dilution-adjusted): -67832000
Buyback yield (%): 0
Retained earnings: -338285000
Receivables turnover: 5.675725075007759
Capitalized R&D asset: 199563000
ROCI (R&D-adjusted, %): 5.149671328991786
FCF margin (%): -41.21546491350658
Rule of 40 score: -41.21546491350658
Financial ratios for XNCR — annual report dated 2023-12-31
Total revenue: 174615000
Operating income: -132362000
Net income: -133133000
Capital expenditures: 18447000
Operating cash flow: -77926000
Depreciation & amortization: 11498000
Net tangible assets: 643087000
Owner earnings: -140082000
Return on net tangible assets (%): -21.782744791917736
Buffett classification: The Gruesome
Stock price: 21.23
Shares outstanding: 74141596
Book value: 662087000
P/B ratio: 2.377370471071022
Market cap (USD): 1574026083.08
Debt to equity: 0.3805285408111019
Current ratio: 8.599107082459582
Quick ratio: 8.599107082459582
Interest coverage ratio: -21.428201392261617
COGS to revenue (%): 0
R&D to revenue (%): 145.2326546974773
SG&A to revenue (%): 30.56953869942445
Free cash flow (dilution-adjusted): -152932000
Buyback yield (%): 0
Retained earnings: -471418000
Receivables turnover: 7.355617338556805
Capitalized R&D asset: 387305210
ROCI (R&D-adjusted, %): -2.3321923129436497
FCF margin (%): -87.58239555593734
Revenue growth (%): 6.097983339308175
Rule of 40 score: -81.48441221662917
Financial ratios for XNCR — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 20.11
Shares outstanding: 74141596
Market cap (USD): 1490987495.56
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for XNCR — annual report dated 2024-12-31
Total revenue: 110493000
Operating income: -178408000
Net income: -232618000
Capital expenditures: 6097000
Operating cash flow: -202188000
Depreciation & amortization: 12107000
Net tangible assets: 659126000
Owner earnings: -226608000
Return on net tangible assets (%): -34.380073005768246
Buffett classification: The Gruesome
Stock price: 22.98
Shares outstanding: 74141596
Book value: 674026000
P/B ratio: 2.5277569056386553
Market cap (USD): 1703773876.08
Debt to equity: 0.3441306418446766
Current ratio: 6.606288315490896
Quick ratio: 6.606288315490896
Interest coverage ratio: -4.868815326256038
COGS to revenue (%): 0
R&D to revenue (%): 206.06373254414305
SG&A to revenue (%): 55.40169965518178
Free cash flow (dilution-adjusted): -264981000
Buyback yield (%): 0
Retained earnings: -704036000
Receivables turnover: 1.8158556426564119
Capitalized R&D asset: 463452450
ROCI (R&D-adjusted, %): -13.379188441988457
FCF margin (%): -239.817001982026
Revenue growth (%): -36.72193110557512
Rule of 40 score: -276.5389330876011
Financial ratios for XNCR — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 22.98
Shares outstanding: 74141596
Market cap (USD): 1703773876.08
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0